Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00880555 · ClinicalTrials.gov registry record

Semantic Memory, Financial Capacity, and Brain Perfusion in Mild Cognitive Impairment (MCI) (CASL)

A clinical trial, sponsored by VA Office of Research and Development.

Completed
Registry status
78
Enrollment target

NCT00880555: Completed study, sponsored by VA Office of Research and Development.

NCT00880555 is a clinical trial that has completed, run by VA Office of Research and Development. The registered enrollment target is 78 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00880555 has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
78 participants
Enrollment target

Study Summary

Alzheimer's disease (AD) often manifests as a memory disorder before dementia develops. Dementia is considered to be present when a person can no longer handle complex activities of daily living, such as managing finances. This study will investigate the relationship between changes in the ability to manage finances and brain perfusion, which will be measured using continuous arterial spin-labeling (an experimental MRI). Subjects will also undergo neuropsychological tests focusing on several types of memory and thought process, with special emphasis on semantic memory. An important question to be addressed is whether changes in function are better predicted by the neuropsychological tests or by the brain scan.

Primary Outcome

At each research visit, participants undertook 5 portions of the Financial Capacity Instrument (Domains 2, 3, 4b, 5, and 7). We report the total FCI score across the five domains tested, which has a range of possible scores from 0-191. Higher scores reflect greater capacity for understanding financial concepts and handling financial tasks.

Trial Details

FieldValue
Enrollment Target 78 participants
Start Date 2009-04
Est. Completion 2014-05
VA Office of Research and Development

1,668 total trials

What the finished NCT00880555 record still lists

NCT00880555 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 78 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT00880555 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00880555 about?

NCT00880555 is a clinical study titled "Semantic Memory, Financial Capacity, and Brain Perfusion in Mild Cognitive Impairment (MCI) (CASL)". Alzheimer's disease (AD) often manifests as a memory disorder before dementia develops. Dementia is considered to be present when a person can no longer handle complex activities of daily living, such as managing finances. This study will investigate the relationship between changes in the ability t...

What is the current status of trial NCT00880555?

This trial is currently completed. The enrollment target is 78 participants. The study started on 2009-04. Estimated completion is 2014-05.

Who is sponsoring clinical trial NCT00880555?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02397668 · 78 participants · NA

    CorMatrix Cor TRICUSPID ECM Valve Replacement Study

  • NCT03321656 · 78 participants · Phase 2

    Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile

  • NCT03687814 · 78 participants · NA

    Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation

  • NCT04018872 · 78 participants · Phase 2

    Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00880555, the US trial registry maintained by the National Library of Medicine. NCT00880555 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.